Rivaroxaban for the treatment and prevention of thromboembolic disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rivaroxaban for the treatment and prevention of thromboembolic disease
Authors
Keywords
-
Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 67, Issue 8, Pages 1119-1132
Publisher
Wiley
Online
2015-06-11
DOI
10.1111/jphp.12387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays
- (2013) Edelgard Lindhoff-Last et al. ANNALS OF MEDICINE
- Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
- (2013) Anuraag R. Kansal et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Practical Management of Rivaroxaban for the Treatment of Venous Thromboembolism
- (2013) Davide Imberti et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- The effect of food on the absorption and pharmacokinetics of rivaroxaban
- (2013) Jan Stampfuss et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- The Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban-An Oral, Direct Factor Xa Inhibitor
- (2013) Dagmar Kubitza et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery
- (2013) Mandana Mahmoudi et al. PHARMACOTHERAPY
- The discovery of rivaroxaban: translating preclinical assessments into clinical practice
- (2013) Dagmar Kubitza et al. Frontiers in Pharmacology
- A new paradigm shift in antithrombotic therapy
- (2013) Anita Pudusseri et al. Frontiers in Pharmacology
- Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Reversal of antithrombotic agents
- (2012) Kenneth A. Bauer AMERICAN JOURNAL OF HEMATOLOGY
- Prevention of VTE in Orthopedic Surgery Patients
- (2012) Yngve Falck-Ytter et al. CHEST
- Parenteral Anticoagulants
- (2012) David A. Garcia et al. CHEST
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- Oral Anticoagulant Therapy
- (2012) Walter Ageno et al. CHEST
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor
- (2012) A. G. G. Turpie et al. THROMBOSIS AND HAEMOSTASIS
- “Triple Therapy” Rather Than “Triple Threat”
- (2011) Hong-Jin Zhao et al. CHEST
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payerʼs Perspective
- (2011) Aurea Duran et al. PHARMACOECONOMICS
- Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
- (2011) Genevieve Contant et al. THROMBOSIS AND HAEMOSTASIS
- Cost–effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden
- (2011) Lars Ryttberg et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- New Anticoagulants
- (2010) John W. Eikelboom et al. CIRCULATION
- Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
- (2010) Stephan H. Schirmer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty
- (2010) Michael Rud Lassen et al. THROMBOSIS AND HAEMOSTASIS
- The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants
- (2010) Meyer Michel Samama THROMBOSIS RESEARCH
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans
- (2009) D. Lang et al. DRUG METABOLISM AND DISPOSITION
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
- (2009) JL Mega et al. LANCET
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
- (2008) H. R. Buller et al. BLOOD
- Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
- (2008) Richard J. Friedman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Guidelines on the diagnosis and management of acute pulmonary embolism
- (2008) et al. EUROPEAN HEART JOURNAL
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now